A microfluidic chip and its application in detecting chemical inhalation toxicity

By designing a detachable microfluidic chip, combined with the series/parallel combination of three-dimensional cell models, the problem of microfluidic chips not being designed in toxicity tests in the prior art is solved, and the problem of multi-organ dynamic interconnection system is difficult to achieve, and the problem of microfluidic chips being designed in the prior art is realized. Efficient and accurate inhalation toxicity testing, especially in cardiotoxicity testing, is of breakthrough significance.

CN118454767BActive Publication Date: 2024-11-26SHANGHAI JIAOTONG UNIV SCHOOL OF MEDICINE
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410799329.2
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-06-20
Publication Date
2024-11-26
Estimated Expiration
2044-06-20

AI Technical Summary

Technical Problem

The existing microfluidic-driven organ chips have problems such as inadequate design, no target organ interactions are considered, and the difficulty in achieving three-dimensional cell culture and reuse in the toxicity test. Especially in the inhalation toxicity test, it is impossible to effectively simulate multi-organ dynamic interconnection. System and cardiotoxicity tests.

Method used

Design a detachable microfluidic chip to simulate a multi-organ dynamic interconnection system, including lungs, blood vessels and other target organs, through a series/parallel combination connection of three-dimensional cell models, to achieve lung toxicity, vascular toxicity and other target organ toxicity tests , the organoid model of differentiation of human cell lines was used to enhance the simulation and accuracy of in vitro tests.

Benefits of technology

It realizes the simulation of multi-organ dynamic interconnection system in vitro, improves the simulation, efficiency and accuracy of inhalation toxicity tests, supports multiple tests to be carried out in parallel, reduces the testing cost, can be reused and recovered cells, and obtains non-secretory index information. , spanning the species differences in animal models.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118454767B_ABST
    Figure CN118454767B_ABST
Patent Text Reader

Abstract

The invention discloses a microfluidic chip and its application in detecting the inhalation toxicity of chemicals. The microfluidic chip comprises an upper substrate and a lower substrate stacked up and down, and a chip part located at the upper substrate; a biological membrane is arranged between the chip part and the lower substrate; a first flow channel and a first tissue cell area located in the first flow channel are formed between the biological membrane and the chip part; a second flow channel and a second tissue cell area located in the second flow channel are formed between the biological membrane and the lower substrate; a third tissue cell area connected to the first flow channel and the second flow channel respectively and a liquid storage area connected to the third tissue cell area are formed between the upper substrate and the lower substrate; the chip part is provided with a first hole and a second hole connected to the first flow channel, and a third hole connected to the second flow channel; the upper substrate is provided with a fourth hole connected to the liquid storage area; the first hole and the third hole are fluid inlet holes; the second hole and the fourth hole are fluid outlet holes.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the multidisciplinary cross-technical fields of toxicology, pharmacology, cell biology, and microfluidic chip design and microfabrication, and relates to the design and manufacture of cell culture devices and toxicity testing devices, in particular, a microfluidic organ chip that integrates different functional units and is used to implement multiple toxicity tests of chemicals. Background Art

[0002] With the continued existence of existing environmental pollution chemicals and long-term emissions from industrial and agricultural production and life, people are exposed to different types of health risks at all times. According to the results of existing meta-analysis, among the 69 known environmental exposures and 83 diseases and causes of death reported in 103 publications, air pollution has the closest association with adverse health outcomes in the human body. Inhalation toxicity testing of chemicals has important practical significance in warning of health risks, promoting the establishment of management standards and protecting human health.

[0003] Inhalation toxicity test, as one of the toxicity tests that must be conducted before various inhalation chemicals are put on the market, is listed as a sub-item of GHS chemical health hazard assessment along with acute toxicity, carcinogenicity, mutagenicity, reproductive toxicity, sensitization, skin irritation, eye damage, and single / repeated contact toxicity of target organs. The current standard method for respiratory toxicity testing is the guidance method of the in vivo experimental guide for mammals (OECD TG403 / 412 / 413) established in 1981. However, due to the special air-liquid interface of the lungs, there is only one inhalation toxicity test sub-item so far, and no in vitro test model other than the in vivo model has been recognized by the regulatory agency.

[0004] At present, chemical inhalation toxicity test data are mostly derived from animal models, but animal models have disadvantages such as high cost, long time consumption, species differences, etc., and with the development of animal ethics such as the "3R" principle of reduction, refinement, and replacement, the species differences between animals and humans and the high-throughput requirements of a large number of compound evaluations, the use of traditional animal experimental methods is increasingly unable to meet. Overcoming species differences and establishing an in vitro high-biofidelity and high-accuracy model dominated by human cells is an inevitable choice for high-throughput screening of chemicals in the future.

[0005] Organ chips are human organ physiological microsystems that are based on microfluidics technology and introduce elements such as cells, extracellular matrix, and sensors that detect cell functions. The main advantage is that it can accurately control cells and their microenvironment. Organ chip technology draws inspiration from the fields of bioengineering and materials to build in vitro models that are more physiologically relevant and suitable for target applications, making up for the shortcomings of simple biological models. It has important application prospects in the construction of in vitro testing systems for chemicals in the future. Summary of the invention

[0006] The purpose of the present invention is to provide a microfluidic chip and its application in detecting the inhalation toxicity of chemicals, combining advanced organoid models and microfluidic-driven organ chips to simulate a multi-organ dynamic interconnection system in vitro, and establish a stable lung toxicity, vascular toxicity and other target organ toxicity testing system and method through series / parallel combination connections between three-dimensional cell models.

[0007] To achieve the above object, the present invention provides the following technical solutions:

[0008] One aspect of the present invention is to provide a microfluidic chip. The microfluidic chip includes an upper substrate and a lower substrate stacked up and down, and a chip part located at the upper substrate; a biological membrane is provided between the chip part and the lower substrate; a first flow channel and a first tissue cell area located in the first flow channel are formed between the biological membrane and the chip part; a second flow channel and a second tissue cell area located in the second flow channel are formed between the biological membrane and the lower substrate; a third tissue cell area connected to the first flow channel and the second flow channel respectively and a liquid storage area connected to the third tissue cell area are formed between the upper substrate and the lower substrate; the chip part A first hole and a second hole connected to the first flow channel, and a third hole connected to the second flow channel are provided; the upper substrate is provided with a fourth hole connected to the liquid storage area; the first hole and the third hole are fluid inlet holes; the second hole and the fourth hole are fluid outlet holes; the first tissue cell area is suitable for loading first tissue cells; the second tissue cell area is suitable for loading second tissue cells; the third tissue cell area is suitable for loading third tissue cells; the liquid storage area is suitable for loading fourth tissue cells; at least one of the first tissue cell area, the second tissue cell area, the third tissue cell area, and the liquid storage area is loaded with corresponding tissue cells.

[0009] Optionally, the upper substrate, the lower substrate and the chip components are detachably connected.

[0010] Optionally, the upper substrate is provided with an assembly hole which passes through from top to bottom so as to assemble the chip parts.

[0011] Optionally, a first flow channel groove open downward is provided on the bottom surface of the chip component; the first flow channel groove and the biological membrane are suitable for forming the first flow channel.

[0012] Optionally, a second flow channel groove open upward is provided on the top surface of the lower substrate; the second flow channel groove and the biological membrane are suitable for forming the second flow channel.

[0013] Optionally, the bottom of the third tissue cell area is higher than the bottom of the liquid storage area.

[0014] Optionally, at least two of the first flow channel, the second flow channel, the first tissue cell area, the second tissue cell area, and the third tissue cell area are respectively arranged in parallel front and back; wherein, the first flow channel, the first tissue cell area and the third tissue cell area correspond one to one; the second flow channel, the second tissue cell area and the third tissue cell area also correspond one to one; at least two of the second flow channels are connected to the third hole; at least two of the third tissue cell areas are connected to the liquid storage area.

[0015] Optionally, each of the first tissue cell regions is suitable for loading the same or different first tissue cells; each of the second tissue cell regions is suitable for loading the same or different second tissue cells; and each of the third tissue cell regions is suitable for loading the same or different third tissue cells.

[0016] Optionally, the microfluidic chip is arranged bilaterally symmetrically.

[0017] The second aspect of the present invention is to provide an application of the microfluidic chip in detecting the inhalation toxicity of chemicals.

[0018] Optionally, the application includes: loading the first tissue cell area with first tissue cells; injecting a culture medium containing a test chemical into the first flow channel through the first hole, and flowing along the first tissue cell area, the third tissue cell area and the storage area; reflecting the first tissue cell toxicity induced by the chemical through the first tissue cells and the exposed culture medium in the storage area.

[0019] Optionally, the application includes: loading the second tissue cell area with second tissue cells; injecting a culture medium containing the test chemical into the second flow channel through the third hole, and flowing along the second tissue cell area, the third tissue cell area and the storage area; reflecting the second tissue cell toxicity induced by the chemical through the second tissue cells and the exposed culture medium in the storage area.

[0020] Optionally, the application includes: loading the first tissue cell area with first tissue cells; loading the second tissue cell area with second tissue cells; loading the third tissue cell area with third tissue cells; injecting a culture fluid containing the test chemical into the first flow channel through the first hole and flowing along the first tissue cell area, the third tissue cell area and the storage area, and injecting a culture fluid containing the test chemical into the second flow channel through the third hole and flowing along the second tissue cell area, the third tissue cell area and the storage area; metabolizing the chemical by the first tissue cells and the second tissue cells, and allowing the metabolized chemical to act on the third tissue cells; reflecting the third tissue cell toxicity induced by the chemical after metabolism by the first tissue cells and the second tissue cells through the exposed culture fluid in the third tissue cells and the storage area.

[0021] Optionally, the application includes: loading the first tissue cell area with first tissue cells; loading the second tissue cell area with second tissue cells; loading the third tissue cell area with third tissue cells; loading the liquid storage area with fourth tissue cells; injecting a culture fluid containing the test chemical into the first flow channel through the first hole and flowing along the first tissue cell area, the third tissue cell area and the liquid storage area, and injecting a culture fluid containing the test chemical into the second flow channel through the third hole and flowing along the second tissue cell area, the third tissue cell area and the liquid storage area; metabolizing the chemical by the first tissue cells, the second tissue cells and the third tissue cells, and allowing the metabolized chemical to act on the fourth tissue cells; reflecting the toxicity of the fourth tissue cells induced by the metabolism of the chemical by the first tissue cells, the second tissue cells and the third tissue cells through the exposed culture fluid in the fourth tissue cells and the liquid storage area.

[0022] Optionally, at least two of the first flow channel (150), the second flow channel (160), the first tissue cell area (151), the second tissue cell area (161), and the third tissue cell area (171) are respectively arranged in parallel in front and back; wherein the first flow channel (150), the first tissue cell area (151), and the third tissue cell area (171) correspond one to one; the second flow channel (160), the second tissue cell area (161), and the third tissue cell area (171) also correspond one to one; at least two of the second flow channels (160) are connected to the third hole (133); at least two of the third tissue cell areas (171) are connected to the liquid storage area (172); accordingly, the application includes: each of the first tissue cell areas is loaded with the first tissue cells; each of the second tissue cell areas is loaded with second tissue cells; each of the third tissue cell areas is loaded with a different third tissue cell; the storage area is loaded with a fourth tissue cell; the culture fluid containing the test chemical is injected into the first flow channel through the first hole and circulated along the first tissue cell area, the third tissue cell area and the storage area, and the culture fluid containing the test chemical is injected into the second flow channel through the third hole and circulated along the second tissue cell area, the third tissue cell area and the storage area; the chemical is metabolized by the first tissue cell, the second tissue cell and different third tissue cells, and the metabolized chemical acts on the fourth tissue cell; the fourth tissue cell and the exposed culture fluid in the storage area reflect the fourth tissue cell toxicity induced by the chemical after metabolism by the first tissue cell, the second tissue cell and different third tissue cells.

[0023] Optionally, the application includes: when the microfluidic chip is arranged symmetrically on the left and right sides, the left and right symmetrical parts thereof respectively perform the same or different chemical inhalation toxicity tests.

[0024] Optionally, the first tissue cells include lung cells; and the second tissue cells include vascular cells.

[0025] Optionally, the third tissue cells include heart cells; or the third tissue cells include liver cells and / or kidney cells, and the fourth tissue cells include heart cells.

[0026] At present, there are still many deficiencies in the design and application of microfluidic-driven organ chips in the existing technology. For example, when used for toxicity testing, microfluidic-driven organ chips often need to be designed and customized according to the research purpose, because the design and integrated functional units of the organ chip must be different according to different research objectives, and there is no universal chip for chemical toxicity testing; for example, the structure of the existing chips used for toxicity testing is relatively simple, and the interaction between different target organs is not considered; and when the chip application object is expanded from two-dimensional to three-dimensional, certain application difficulties arise, and it is impossible to construct organoid chips or only support a limited number of three-dimensional cell cultures; for example, due to the variety of three-dimensional cell culture methods, which vary with the choice of supporting external environment (such as hydrogels, matrix glue, scaffolds, bioreactors, etc.), the requirements for organ chips involved in these culture methods are more detailed and specific, which also makes it difficult to meet the "culture" and "toxicity testing" at the same time. Therefore, the development of a detachable organ chip is more practical for detecting important indicators in the field of toxicology; for example, among the existing chips, the lung organ chip has been developed since 2010. Since then, there has been no significant breakthrough and improvement in materials and structures. There are still the following shortcomings in using it for toxicity testing and drug development: 1) The model is a fully enclosed structure, and a single chip can only complete one test and cannot be reused; 2) The cost of PDMS material molding is high; 3) PDMS material has a strong adsorption capacity for chemicals in the convection channel, which can easily affect the final concentration of the compound; 4) The lung modules used are still mostly 2D cell models. Therefore, the development of a detachable lung model chip that can meet the existence of gas-liquid exchange interface and three-dimensional cell culture is of great practical significance for the high-throughput in vitro inhalation toxicity testing; for example, common respiratory diseases and the use of related drugs can cause damage to other target organs, such as arrhythmias, heart block, changes in myocardial contractility, decreased vascular resistance and hypotension in cardiovascular events, and cardiovascular toxicity has also become the primary target organ for systemic toxic side effects caused by drugs in lung cancer patients, but existing microfluidic chips are still unable to complete chemical cardiac toxicity testing in in vitro models.

[0027] Compared with the prior art, the technical solution of the present invention has at least the following beneficial effects:

[0028] 1) The present invention combines advanced organoid models and microfluidic-driven organ chips to simulate a multi-organ dynamic interconnection system in vitro, and establishes a stable lung toxicity, vascular toxicity and other target organ toxicity test system and method through series / parallel combination connection between three-dimensional cell models;

[0029] 2) The present invention adopts a microfluidic chip designed with specific functional units, which can load lungs, blood vessels, and other organoid models such as lung organoids and heart organoids obtained by three-dimensional culture to simulate the physiological system of "lung-other organ circulation" dynamic interconnection in vitro, and can carry out "respiratory-circulatory" inhalation toxicity test of chemicals based on "lung toxicity", "vascular toxicity" and "other target organ toxicity", as well as "metabolic toxicity / reduction" process, according to each toxic phenotype and effect, to explore the direct toxic effects of inhaled chemicals on the lungs and blood vessels and the indirect toxic effects of chemicals on other target organs after metabolism;

[0030] 3) The microfluidic chip of the present invention realizes the serial combination between organoids, and simulates the physiological characteristics of chemicals after being inhaled into the human body, passing through the "lung gas-blood barrier" and "vascular endothelial metabolism" and then acting on other target organ systems through the circulatory system, thereby improving the simulation degree, efficiency and accuracy of the "breathing-circulation" mode of in vitro toxicity testing. It is an important application practice to establish an integrated toxicity testing system in response to the call of "animal welfare", based on the idea of ​​toxicological alternatives and following the "4R" principle (Reduction, Replacement, Refinement, Responsibility);

[0031] 4) The microfluidic chip of the present invention realizes the serial combination of organoids, and can establish a heart-lung serial module in the in vitro model, while making the lungs both the target tissue for inhaled substances and the entrance to the systemic circulation, thus achieving a comprehensive and effective evaluation of the inhalation toxicity of chemicals in the in vitro model, and improving the simulation, efficiency and accuracy of in vitro toxicity testing;

[0032] 5) The present invention can carry out multiple tests simultaneously and in parallel on a single microfluidic chip, such as "pulmonary toxicity", "vascular toxicity", "other target organ toxicity" and "other target organ toxicity after metabolism through the lung air-blood barrier and vascular endothelium" tests that take metabolic factors into consideration;

[0033] 6) The microfluidic chip of the present invention is detachable, which not only realizes the recycling and reuse of the chip components after disassembly, but also increases the utilization rate of the biological membrane and reduces the testing cost. Moreover, after disassembly, the three-dimensional or two-dimensional cells in each area can be recovered separately, and then the biological effects in the recovered cells can be further detected in combination with the toxicity test scheme or toxicology experiment needs, so as to obtain non-secretory indicator information that cannot be detected in the culture medium, which has higher practicality for detecting important indicators in the field of toxicology;

[0034] 7) The microfluidic chip of the present invention can not only load and culture three-dimensional cell models, but also be compatible with two-dimensional cell culture;

[0035] 8) The three-dimensional models used in the microfluidic chip of the present invention are all organoid models differentiated from human cell lines, which transcend the species differences of animal models and more effectively indicate the toxic characteristics of inhaled chemicals to humans. BRIEF DESCRIPTION OF THE DRAWINGS

[0036] Figure 1 A schematic diagram of the microfluidic chip assembly in an embodiment of the present invention;

[0037] Figure 2 is an axonometric view of the lower substrate in an embodiment of the present invention;

[0038] Figure 3 is a top view of the lower substrate in an embodiment of the present invention;

[0039] Figure 4 is an axonometric view of an upper substrate in an embodiment of the present invention;

[0040] Figure 5 is a bottom view of the upper substrate in an embodiment of the present invention;

[0041] Figure 6 is an axonometric view of a substrate part in an embodiment of the present invention;

[0042] Figure 7 A bottom view of a substrate part in an embodiment of the present invention;

[0043] Figure 8 It is an axonometric view of the baffle part in the embodiment of the present invention;

[0044] Fig. 9 A cross-sectional view of the microfluidic chip at the first flow channel and the second flow channel along the width direction in an embodiment of the present invention;

[0045] Fig.10 Another cross-sectional view of the microfluidic chip at the first flow channel and the second flow channel along the width direction in an embodiment of the present invention;

[0046] Fig.11 A cross-sectional view of the microfluidic chip at the third tissue cell region along the width direction in an embodiment of the present invention;

[0047] Fig.12 This is another cross-sectional view of the microfluidic chip at the third tissue cell region along the width direction in an embodiment of the present invention.

[0048] Description of reference numerals:

[0049] 10 microfluidic chip, 110 upper substrate, 111 fourth hole, 112 assembly hole, 113 upper tissue cell groove, 114 upper liquid storage tank, 120 lower substrate, 121 second flow channel groove, 122 lower tissue cell groove, 123 lower liquid storage tank, 124 groove, 130 substrate parts, 131 first hole, 132 second hole, 133 third hole, 134 first flow channel groove, 135 convex strip, 140 biological membrane, 150 first flow channel, 151 first tissue cell area, 160 second flow channel, 161 second tissue cell area, 171 third tissue cell area, 172 liquid storage area, 180 baffle parts. DETAILED DESCRIPTION

[0050] The present invention is described in detail below in conjunction with specific embodiments. The following embodiments will help those skilled in the art to further understand the present invention, but the following embodiments should not be regarded as limiting the present invention. It should be noted that, for those of ordinary skill in the art, some adjustments and improvements can also be made without departing from the concept of the present invention. These all belong to the protection scope of the present invention.

[0051] For the convenience of description, only the parts related to the present invention are shown in the drawings instead of all structures. In addition, the same or similar reference numerals may be used in the drawings to refer to the same or similar components in different embodiments. Example

[0052] This embodiment provides a microfluidic chip.

[0053] Reference Figures 1 to 11 The microfluidic chip 10 may include an upper substrate 110 and a lower substrate 120 stacked one above the other, and a substrate part 130 located at the upper substrate 110 .

[0054] In some specific examples, the upper substrate 10, the lower substrate 120 and the substrate part 130 can all be made of transparent or translucent PC, PMMA, PS and other materials. In addition, PDMS material should be avoided because PDMS material has a strong adsorption capacity for chemicals and it is difficult to ensure the consistency of the concentration of chemicals in the toxicity test.

[0055] In some specific examples, the upper substrate 110 , the lower substrate 120 , and the substrate parts 130 are detachably connected to facilitate the recycling of these components.

[0056] In some specific examples, the upper substrate 110 and the lower substrate 120 may be connected by buckling, pressing, auxiliary fixing, sealing after chemical treatment, etc.

[0057] In some specific examples, the upper substrate 110 is provided with an assembly hole 112 which passes through from top to bottom for assembling the substrate part 130 .

[0058] In some specific examples, a convex strip 135 is further provided at the bottom of the substrate part 130. Correspondingly, a groove 124 is provided on the lower substrate 120. By inserting or pulling out the convex strip 135 into or out of the groove 124, the substrate part 130 can be detachably assembled with the lower substrate 120.

[0059] In a specific implementation, a biological membrane 140 is disposed between the substrate part 130 and the lower substrate 120. Specifically, the biological membrane 140 may be a PDMS membrane.

[0060] A first flow channel 150 and a first tissue cell region 151 located in the first flow channel 150 are formed between the biomembrane 140 and the substrate part 130. A second flow channel 160 and a second tissue cell region 161 located in the second flow channel 160 are formed between the biomembrane 140 and the lower substrate 120. The first flow channel 150 and the second flow channel 160 are suitable for carrying and allowing the culture fluid to flow. The first tissue cell region 151 and the second tissue cell region 161 are suitable for loading the first tissue cells and the second tissue cells, respectively.

[0061] In a specific implementation, the first flow channel 150 and the second flow channel 160 are arranged correspondingly up and down.

[0062] In some specific examples, a first flow channel 134 open downward is disposed on the bottom surface of the substrate part 130 . The first flow channel 134 is suitable for defining a first flow channel 150 together with the biological membrane 140 . The first tissue cell area 151 is located in the first flow channel 150 .

[0063] In a specific implementation, the first tissue cells are seeded on the biological membrane 140 and can be fixed by pressure fixation or other chemical methods.

[0064] In some specific examples, the top surface of the lower substrate 120 is provided with a second flow channel groove 121 open upward. The second flow channel groove 121 is suitable for defining a second flow channel 160 together with the biological membrane 140. The second tissue cell area 161 is located in the second flow channel 160.

[0065] In a specific implementation, the second tissue cells are seeded under the biological membrane 140 and can be fixed by pressure fixation or other chemical means.

[0066] In a specific implementation, the length, width, inner depth and slope of the first flow channel 150 and the second flow channel 160 can be specifically designed as needed.

[0067] A third tissue cell area 171 connected to the first flow channel 150 and the second flow channel 160, and a liquid storage area 172 connected to the third tissue cell area 171 are formed between the upper substrate 110 and the lower substrate 120. The third tissue cell area 171 is suitable for loading third tissue cells; and the liquid storage area 172 is suitable for receiving and storing culture fluid.

[0068] In some specific examples, the liquid storage area 172 is also suitable for loading fourth tissue cells.

[0069] In some specific examples, the bottom surface of the upper substrate 110 and the top surface of the lower substrate 120 are respectively provided with an upper tissue cell groove 113 and a lower tissue cell groove 122. When the upper substrate 110 and the lower substrate 120 are attached to each other, the upper tissue cell groove 113 and the lower tissue cell groove 122 are assembled to form a third tissue cell area 171.

[0070] In some specific examples, both the upper tissue cell groove 113 and the lower tissue cell groove 122 may be semicircular grooves.

[0071] In some specific examples, the radius of the semicircular grooves of the upper tissue cell groove 113 and the lower tissue cell groove 122 are both 300 μm, so that the third tissue cell area 171 formed by the upper and lower parts is suitable for loading tissue cells.

[0072] In some specific examples, a baffle part 180 is further provided in the third tissue cell area 171 to prevent the third tissue cells from being washed away when the culture fluid flows.

[0073] In a specific implementation, the first flow channel 150 and the second flow channel 160 which are arranged correspondingly up and down are respectively connected to the third tissue cell area 171 .

[0074] In some specific examples, the bottom surface of the upper substrate 110 and the top surface of the lower substrate 120 are respectively provided with an upper liquid reservoir 114 and a lower liquid reservoir 123. When the upper substrate 110 and the lower substrate 120 are attached to each other, the upper liquid reservoir 114 and the lower liquid reservoir 123 are assembled to form a liquid storage area 172.

[0075] In a specific implementation, the length, width, internal depth and slope of the liquid storage area 172 can also be specifically designed as needed.

[0076] In a specific implementation, the liquid storage area 172 and the third tissue cell area 171 are connected via a flow channel.

[0077] In some specific examples, the bottom of the third tissue cell area 171 is higher than the bottom of the liquid storage area 172, so that the pressure can be reduced while the culture fluid flows therein, thereby avoiding leakage.

[0078] In some specific examples, the bottom of the third tissue cell area 171 is 500 μm higher than the bottom of the liquid storage area 172 , so that the pressure can be reduced while the culture solution flows therein, thereby avoiding leakage.

[0079] In some specific examples, the upper substrate 110 and the lower substrate 120 can be sealed by conventional bonding, sealing, etc. to ensure that the culture solution can flow smoothly in various channels and areas between the upper substrate 110 and the lower substrate 120.

[0080] The substrate part 130 is also provided with a first hole 131 and a second hole 132 connected to the first flow channel 150. The first hole 131 is a fluid inlet hole, and the second hole 132 is a fluid outlet hole. The fluid includes gas and liquid, and the liquid includes a culture medium. The first tissue cells loaded in the first tissue cell area 151 are suitable for communicating with the outside through the first hole 131 and the second hole 132 to replace the culture medium or complete gas exposure.

[0081] The substrate part 130 is also provided with a third hole 133 communicating with the second flow channel 160. The third hole 133 is a liquid inlet hole, so that the culture fluid can enter the second flow channel 160. The second tissue cells loaded in the second tissue cell area 161 can only be given nutrition through the third hole 133.

[0082] The upper substrate 110 is provided with a fourth hole 111 communicating with the liquid storage area 172 . The fourth hole 111 is a liquid outlet hole, so that the culture liquid can flow out of the liquid storage area 172 .

[0083] In some specific examples, at least two of the first flow channel 150 , the second flow channel 160 , the first tissue cell area 151 , the second tissue cell area 161 , and the third tissue cell area 171 are respectively arranged in parallel in front and back. Among them, the first flow channel 150, the first tissue cell area 151 and the third tissue cell area 171 correspond one to one, and each first flow channel 150 is respectively provided with a first tissue cell area 151, and each first flow channel 150 is respectively connected with a third tissue cell area 171; the second flow channel 160, the second tissue cell area 161 and the third tissue cell area 171 also correspond one to one, and each second flow channel 160 is respectively provided with a second tissue cell area 162, and each second flow channel 160 is respectively connected with a third tissue cell area 171; each first flow channel 150 is respectively provided with its own first hole 131 and second hole 132; only one third hole 133 is provided, and the third hole 133 is connected with all second flow channels 160; the first flow channel 150 and the second flow channel 160 arranged correspondingly up and down are connected with the same third tissue cell area 171; all third tissue cell areas 171 are connected with the liquid storage area 172.

[0084] In some specific examples, two of the first flow channel 150, the second flow channel 160, the first tissue cell area 151, the second tissue cell area 161, and the third tissue cell area 171 can be respectively arranged in parallel front and back. In this case, the microfluidic chip 10 has two first flow channels 150, two first tissue cell areas 151, two second flow channels 160, two second tissue cell areas 161, two third tissue cell areas 171 and a liquid storage area 172.

[0085] In some specific examples, the microfluidic chip 10 may also be arranged in a left-right arrangement with at least two groups of corresponding flow channels and cell loading areas. Figure 1 As shown, the microfluidic chip 10 is symmetrically provided with two groups of corresponding flow channels and cell loading areas, wherein each group has two first flow channels 150, two first tissue cell areas 151, two second flow channels 160, two second tissue cell areas 161, two third tissue cell areas 171 and a liquid storage area 172. In this case, the two first flow channels 150 in each group are respectively provided with a first tissue cell area 151, a first hole 131 and a second hole 132, and the two first flow channels 150 in each group are respectively connected to a third tissue cell area 171; the two second flow channels 160 in each group are respectively provided with a second tissue cell area 161, and the two second flow channels 160 in each group are respectively connected to a third tissue cell area 171; each group is provided with a third hole 133, and the third hole 133 is connected to the two second flow channels 160 in the group; the first flow channels 150 and the second flow channels 160 arranged correspondingly up and down in each group are connected to the same third tissue cell area 171; the two third tissue cell areas 171 in each group are connected to the liquid storage area 172 of the group. In specific implementation, different groups can perform different tests or operations.

[0086] In the embodiment of the present invention, the first tissue cell area 151 is suitable for loading the first tissue cell, the second tissue cell area 161 is suitable for loading the second tissue cell, the third tissue cell area 171 is suitable for loading the third tissue cell, and the liquid storage area 172 is suitable for loading the fourth tissue cell. In addition, in one test or operation, at least one of the first tissue cell area 151, the second tissue cell area 161, the third tissue cell area 171, and the liquid storage area 172 is loaded with corresponding tissue cells.

[0087] When at least two of the first flow channel 150, the second flow channel 160, the first tissue cell area 151, the second tissue cell area 161, and the third tissue cell area 171 are respectively provided, each first tissue cell area 151 is suitable for loading the same or different first tissue cells; each second tissue cell area 161 is suitable for loading the same or different second tissue cells; each third tissue cell area 171 is suitable for loading the same or different third tissue cells.

[0088] When the microfluidic chip 10 can be arranged in left and right order with at least two groups of corresponding flow channels and cell loading areas, each group can perform different tests or operations respectively. Example

[0089] This embodiment provides an application of the microfluidic chip 10 described in Embodiment 1 in detecting the inhalation toxicity of chemicals.

[0090] In this embodiment, the first tissue cell area 151 is suitable for loading a first tissue cell model including a lung cell model; the second tissue cell area 161 is suitable for loading a second tissue cell model including a vascular cell model; and the third tissue cell area 171 and the liquid storage area 172 are suitable for loading other tissue cell models.

[0091] In a specific implementation, the lung cells include three-dimensional lung cells. The three-dimensional lung cells may include lung cell spheres or lung organoids obtained by induced differentiation of human pluripotent stem cell lines, human induced pluripotent stem cell lines, primary cells, adult stem cell lines or lung tissue; the three-dimensional culture medium and method may include hydrogel, matrix glue, scaffold, bioreactor culture with or without microcarriers.

[0092] When loading the three-dimensional lung cell model in the first tissue cell area 151, the scaffold or microcarrier needs to be removed and only the three-dimensional lung cell model obtained at the end of the culture is loaded. The area where the lung cell spheres are located can be fixed on the PDMS membrane using matrix glue, and the two-dimensional model can be directly loaded on the PDMS membrane.

[0093] After the lung cell model is loaded in the first tissue cell area 151 , the lung cells are connected to the outside through the first hole 131 and the second hole 132 to replace the culture medium or complete gas exposure.

[0094] When loading the two-dimensional or three-dimensional cell models related to "blood vessels" in the second tissue cell area 161, the scaffold or microcarrier needs to be removed, the three-dimensional cell model is fixed under the PDMS membrane using matrix glue, and the two-dimensional cell line is seeded on the PDMS membrane by gravity through the inverted chip; in addition, a tubular vascular structure can be formed by pre-coating the flow channel with matrix glue.

[0095] After the second tissue cell area 161 is loaded with the vascular cell model, nutrients are given through the third hole 133 .

[0096] When loading three-dimensional cell models from other tissue sources in the third tissue cell area 171, it is necessary to remove the culture medium, scaffold or microcarrier, and only load the three-dimensional cell model obtained at the end of the culture. After the cell group is stuck in the upper tissue cell groove 113 or the lower tissue cell groove 122 and is not easy to roll, start the subsequent operation. When loading two-dimensional cultured cells in the third tissue cell area 171, after coating with common culture matrix (such as gelatin, matrix glue, etc.), the cells can be inoculated in the upper tissue cell groove 113 or the lower tissue cell groove 122 and placed in a constant temperature incubator at 37°C and containing 5% carbon dioxide for culture. After the cells grow to a suitable density, start the subsequent operation.

[0097] When other cell models are loaded in the third tissue cell area 171 , a baffle component 180 may be disposed in the third tissue cell area 171 to prevent the cell models therein from being washed away when the culture fluid flows.

[0098] In addition, other tissue cell models may be loaded in the liquid storage area 172 with reference to the situation of the third tissue cell area 171 .

[0099] In a specific implementation, the cell types suitable for loading in the third tissue cell area 171 and the liquid storage area 172 can be selected according to the purpose of the toxicity test, including but not limited to three-dimensionally cultured neural cells, cardiomyocytes, vascular endothelial cells, various cells derived from lung tissue, tumor cells, etc.

[0100] After cell loading or culture is completed, the upper substrate 10, the lower substrate 120 and the substrate part 130 are placed one by one and connected to the capillary or hose of the microfluidic device. The culture solution containing or not containing the test compound can enter the microfluidic chip 10 through the capillary through the microfluidic device.

[0101] In specific implementation, the microfluidic device needs to have a flow rate of at least 5 μL / min, a maximum pressure resistance of no less than 200 bar, and an operating temperature between 0 and 40° C. The inner diameter of the capillary, hose or metal tube connected to the microfluidic chip 10 is no more than 500 μm.

[0102] In a first specific example, the microfluidic chip 10 can be used to detect chemical-induced lung toxicity.

[0103] In a specific implementation, the lung cell model is loaded only in the first tissue cell area 151. The culture fluid containing the test chemical is injected into the first flow channel 150 through the first hole 131, that is, the culture fluid containing the test chemical is injected into the first flow channel 150 through the top of the biological membrane 140, and flows along the first tissue cell area 151, the third tissue cell area 171 and the liquid storage area 172. The lung cells in the first tissue cell area 151 and the culture fluid in the liquid storage area 172 after exposure are suitable for reflecting the lung toxicity induced by the chemical.

[0104] In a second specific example, the microfluidic chip 10 can be used to detect chemical-induced vascular toxicity.

[0105] In a specific implementation, the vascular cell model is loaded only in the second tissue cell area 161. The culture fluid containing the test chemical is injected into the second flow channel 160 through the third hole 133, that is, the culture fluid containing the test chemical is injected into the second flow channel 160 through the bottom of the biological membrane 140, and flows along the second tissue cell area 161, the third tissue cell area 171 and the liquid storage area 172. The vascular cells in the second tissue cell area 161 and the culture fluid in the liquid storage area 172 after exposure are suitable for reflecting the vascular toxicity induced by the chemical.

[0106] In a third specific example, the microfluidic chip 10 can be used to detect other target organ toxicity induced by chemicals entering the circulatory system after being metabolized.

[0107] In a specific implementation, a lung cell model is loaded in the first tissue cell area 151; a vascular cell model is loaded in the second tissue cell area 161; and other tissue cell models are loaded in the third tissue cell area 171. The culture fluid containing the test chemical is injected into the first flow channel 150 through the first hole 131 and flows along the first tissue cell area 151, the third tissue cell area 171 and the liquid storage area 172. At the same time, the culture fluid containing the test chemical is also injected into the second flow channel 160 through the third hole 133 and flows along the second tissue cell area 161, the third tissue cell area 171 and the liquid storage area 172. The lung cells in the first tissue cell area 151 and the vascular cells in the second tissue cell area 161 are suitable for preliminary metabolism of the chemical, and the metabolized chemical acts on the third tissue cells. The other tissue cells in the third tissue cell area 171 and the culture fluid in the liquid storage area 172 after exposure are suitable for reflecting the toxicity of other target organs induced by the chemical after being metabolized and entering the circulatory system.

[0108] In a further specific example, a cardiac cell model may be loaded in the third tissue cell area 171. In this case, the microfluidic chip 10 may be used to detect cardiac toxicity induced by compounds entering the circulatory system after being metabolized.

[0109] The microfluidic chip 10 in this specific example is loaded with three tissue cell models, among which the lung cell model and the vascular cell model are separated and connected in parallel by a biological membrane 140, thereby realizing the simulation of the "pulmonary air-blood barrier" and "endothelial metabolism". Subsequently, other target organ models such as the heart cell model are connected in series to construct a dynamic interconnected model of "lungs + other organs", thereby realizing the simultaneous acquisition of multiple toxicity information of the test compounds in a single experiment.

[0110] In a fourth specific example, the microfluidic chip 10 can be used to detect the toxicity of chemicals to terminal target organs after being metabolized by multiple organs.

[0111] In a specific implementation, the first flow channel 150, the second flow channel 160, the first tissue cell area 151, the second tissue cell area 161, and the third tissue cell area 171 in the microfluidic chip 10 are respectively arranged in parallel. In addition, the two first tissue cell areas 151 are loaded with lung cell models; the two second tissue cell areas 161 are loaded with vascular cell models; the two third tissue cell areas 171 are loaded with different other tissue organ cell models; and the terminal tissue organ cell model is loaded in the liquid storage area 172. The culture fluid containing the test chemical is injected into the first flow channel 150 through the first hole 131 and flows along the first tissue cell area 151, the third tissue cell area 171 and the liquid storage area 172. At the same time, the culture fluid containing the test chemical is also injected into the second flow channel 160 through the third hole 133 and flows along the second tissue cell area 161, the third tissue cell area 171 and the liquid storage area 172. The lung cells in the first tissue cell area 151, the blood vessel cells in the second tissue cell area 161, and the different other organ cells in the third tissue cell area 171 are suitable for metabolizing chemicals, and the metabolized chemicals act on the terminal tissue organ cells in the liquid storage area 172. The terminal tissue organ cells in the liquid storage area 172 and the culture fluid in the liquid storage area 172 after exposure are suitable for reflecting the terminal tissue organ cell toxicity induced by the metabolism of chemicals by lung cells, blood vessel cells, and the different other organ cells in the third tissue cell area 171.

[0112] In a further specific example, the two third tissue cell regions 171 are respectively loaded with a liver cell model and a kidney cell model, and the liquid storage region 172 is loaded with a heart cell model. In this case, the microfluidic chip 10 can be used to detect the toxicity of chemicals to heart cells after being metabolized by multiple organs such as lung cells, vascular cells, liver cells, and kidney cells.

[0113] In the fifth specific example, the microfluidic chip 10 is symmetrically provided with two groups of corresponding flow channels and cell loading areas. In this case, the left and right groups can respectively perform different chemical inhalation toxicity tests. For example, the chemical-induced lung toxicity test and the test of other target organ toxicity induced by the respiratory circulatory system before and after the action can be performed on the left and right sides of the microfluidic chip 10.

[0114] In the process of detecting the inhalation toxicity of chemicals, the action time of the chemicals can be recorded from the time when the microfluidic chip 10 is filled with the culture solution, and the length of time can be determined according to the requirements of the toxicity test.

[0115] Furthermore, toxic effect indicators can also be detected.

[0116] Specifically, secretory indicators of the overall toxicity of the "respiratory-circulatory" system, such as aspartate aminotransferase, lactate dehydrogenase, etc., can be detected in the culture fluid flowing out of the fourth hole 111 of the liquid storage area 172 or in the culture fluid of the liquid storage area 172. Taking "cardiotoxicity" as an example, when the third tissue cell area 171 is loaded with a three-dimensional heart cell model, secretory indicators of "cardiotoxicity", such as creatine kinase, troponin, etc., can be detected in the culture fluid.

[0117] After the test is completed, the upper substrate 110, the lower substrate 120, and the substrate part 130 can be disassembled, and the three-dimensional or two-dimensional cells in each area can be recovered separately. Then, the biological effects in the recovered cells can be further detected in combination with the toxicity test plan or toxicology experiment, such as but not limited to non-secretory indicators such as enzyme activity, protein abundance, mRNA expression, cell survival and apoptosis.

[0118] In summary, it can be seen from this embodiment that the microfluidic chip 10 designed with specific functional units of the present invention can load lungs, blood vessels, and other organoid models such as lung organoids, heart organoids, etc. obtained by three-dimensional culture to simulate the physiological system of the dynamic interconnection of "lung-other organ circulation" in vitro, and can carry out "respiration-circulation" inhalation toxicity testing of chemicals based on "lung toxicity", "vascular toxicity" and "other target organ toxicity", as well as "metabolic toxicity / detoxification" processes according to various toxic phenotypes and effects, to explore the direct toxic effects of inhaled chemicals on the lungs and blood vessels and the indirect toxic effects of chemicals on other target organs after metabolism.

[0119] The preferred embodiments of the present invention have been specifically described above, but the present invention is not limited to the embodiments. Those skilled in the art may make various equivalent modifications or substitutions without violating the spirit of the present invention. These equivalent modifications or substitutions are all included in the scope defined by the claims of this application.

Claims

1. A method for detecting the inhalation toxicity of chemicals using a microfluidic chip (10), characterized in that: The microfluidic chip (10) comprises an upper substrate (110) and a lower substrate (120) stacked one above the other, and a substrate part (130) located at the upper substrate (110); a biological membrane (140) is provided between the substrate part (130) and the lower substrate (120); a first flow channel (150) is formed between the biological membrane (140) and the substrate part (130), and a first tissue cell region (151) is located in the first flow channel (150); a second flow channel (160) is formed between the biological membrane (140) and the lower substrate (120), and a second tissue cell region (161) is located in the second flow channel (160); A third tissue cell area (171) connected to the first flow channel (150) and the second flow channel (160) respectively, and a liquid storage area (172) connected to the third tissue cell area (171) are formed between the upper substrate (110) and the lower substrate (120), wherein the first flow channel (150) is connected to the third tissue cell area (171) through the biological membrane (140) and the second flow channel (160); the substrate part (130) is provided with a first hole (131) and a second hole (132) connected to the first flow channel (150), and a third hole (133) connected to the second flow channel (160); the upper substrate (110) is provided with a a fourth hole (111) connected to the liquid storage area (172); the first hole (131) and the third hole (133) are fluid inlet holes; the second hole (132) and the fourth hole (111) are fluid outlet holes; the first tissue cell area (151) is suitable for loading first tissue cells; the second tissue cell area (161) is suitable for loading second tissue cells; the third tissue cell area (171) is suitable for loading third tissue cells; the liquid storage area (172) is suitable for loading fourth tissue cells; the first tissue cell area (151), the second tissue cell area (161), the third tissue cell area (171) and the liquid storage area (172) are loaded with corresponding tissue cells; The upper substrate (110), the lower substrate (120), and the substrate part (130) are detachably connected; the bottom surface of the substrate part (130) is provided with a first flow channel groove (134) open downward; the first flow channel groove (134) and the biological membrane (140) are suitable for forming the first flow channel (150); the top surface of the lower substrate (120) is provided with a second flow channel groove (121) open upward; the second flow channel groove (121) and the biological membrane (140) are suitable for forming the second flow channel (160); the first tissue cell area (151) is loaded with first tissue cells; the second tissue cell area (161) is loaded with second tissue cells; The third tissue cell area (171) is loaded with third tissue cells; the liquid storage area (172) is loaded with fourth tissue cells; the method comprises: a culture fluid containing a test chemical is injected into the first flow channel (150) through the first hole (131) and flows along the first tissue cell area (151), the second tissue cell area (161), the third tissue cell area (171) and the liquid storage area (172) in sequence; and a culture fluid containing a test chemical is injected into the second flow channel (160) through the third hole (133) and flows along the second tissue cell area (161), the third tissue cell area (171) and the liquid storage area (172); the first tissue cells, the second tissue cells and the third tissue cells are suitable for metabolizing the chemical, and the metabolized chemical acts on the fourth tissue cells; The fourth tissue cells and the culture fluid in the liquid storage area (172) after exposure are suitable for reflecting the toxicity of the fourth tissue cells induced by the metabolism of the chemical by the first tissue cells, the second tissue cells and the third tissue cells.

2. The method according to claim 1, characterized in that At least two of the first flow channel (150), the second flow channel (160), the first tissue cell area (151), the second tissue cell area (161), and the third tissue cell area (171) are respectively arranged in parallel in front and back; wherein the first flow channel (150), the first tissue cell area (151) and the third tissue cell area (171) correspond one to one; the second flow channel (160), the second tissue cell area (161) and the third tissue cell area (171) also correspond one to one; at least two of the second flow channels (160) are connected to the third hole (133); at least two of the third tissue cell areas (171) are connected to the liquid storage area (172); each of the first tissue cell areas (151) is loaded with first tissue cells; each of the second tissue cell areas (161) is loaded with second tissue cells; each of the third tissue cell areas (171) is loaded with different third tissue cells; The storage area (172) is loaded with fourth tissue cells; the culture fluid containing the test chemical is injected into the first flow channel (150) through the first hole (131) and flows along the first tissue cell area (151), the second tissue cell area (161), the third tissue cell area (171) and the storage area (172); and the culture fluid containing the test chemical is injected into the second flow channel (160) through the third hole (133) and flows along the second tissue cell area (161), the third tissue cell area (171) and the storage area (172); the first tissue cells, the second tissue cells and different third tissue cells are suitable for metabolizing the chemical, and the metabolized chemical acts on the fourth tissue cells; the fourth tissue cells and the culture fluid after exposure in the storage area (172) are suitable for reflecting the toxicity of the fourth tissue cells induced by the metabolism of the chemical by the first tissue cells, the second tissue cells and different third tissue cells.

3. The method according to claim 1 or 2, characterized in that: The microfluidic chip (10) is arranged bilaterally symmetrically, so as to be suitable for respectively performing inhalation toxicity tests on the same or different chemicals.